Get startedLog in
    Picture of Eckert & Ziegler SE logo

    EUZ — Eckert & Ziegler SE News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousMid CapFalling Star
    All News

    Brief: Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler

    Picture of Eckert & Ziegler SE logoEckert & Ziegler SE
    22/07/2026 06:30
    BRIEF-Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler
    July 22 (Reuters) - ECKERT & ZIEGLER SE EUZG.DE:
    • BAFIN REVIEW CONCERNS RECOGNITION OF PENTIXAPHARM SPIN-OFF IN 2024 CONSOLIDATED FINANCIAL STATEMENTS. POTENTIAL INCOME FROM DISCONTINUED OPERATIONS WITHOUT IMPACT ON OPERATING KEY FIGURES.
    • BAFIN INITIATES SPECIAL REVIEW OF ECKERT & ZIEGLER 2024 CONSOLIDATED FINANCIAL STATEMENTS
    • BAFIN REVIEWS ACCOUNTING OF PENTIXAPHARM AG SPIN-OFF IN 2024 FINANCIAL STATEMENTS
    • IN CLOSE AND CONSTRUCTIVE COMMUNICATION WITH BAFIN REGARDING THIS MATTER
    Source text: ID:nEQ3W1KVQa
    Further company coverage: EUZG.DE


     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Eckert & Ziegler SE

    See all news